Baseline LDH and SII levels emerged as key predictors of survival outcomes in individuals with advanced melanoma receiving first-line anti-PD-1 therapy.
The post Pretreatment LDH and SII Predict Survival in Melanoma first appeared on Physician’s Weekly.
